In endothelial cells, RUNX2′s DNA binding activity and the angiogenic phenotype were regulated by hyperglycemia, that is, the glucose-mediated intracellular pathway and redox status, suggesting the potential role of RUNX2 in orchestrating tumor-associated angiogenesis [30]. Here, RUNX2 is linked to neoplasm.